Skip to main content
Clinical Trials/ACTRN12607000140459
ACTRN12607000140459
Completed
Phase 2

Pilot study in patients with mild to moderate acne utilising a facial cleanser, topical gel and oral supplement compared to placebo for treatment of acne.

ifeSource Group Holdings Pty Ltd0 sites20 target enrollmentFebruary 23, 2007

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Mild to Moderate Acne vulgaris
Sponsor
ifeSource Group Holdings Pty Ltd
Enrollment
20
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 23, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ifeSource Group Holdings Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • Subjects with mild to moderate inflammatory acne; of any racial/ethnic group.

Exclusion Criteria

  • Oral retinoid use within 2 years of entry into the study; Systemic acne therapies within 4 weeks of entry into the study; Subjects with predominantly comedonal acne; Subjects with predominant retention acne.

Outcomes

Primary Outcomes

Not specified

Similar Trials